Results 41 to 50 of about 1,231,050 (361)

Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: Results of the MAP study [PDF]

, 2000
In a randomized clinical trial with an observation period of 2.5 years, the differential efficacy of lithium versus carbamazepine was compared in 171 bipolar patients (DSM-IV).
Greil, Waldemar, Kleindienst, Nikolaus
core   +1 more source

Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study

Complex Psychiatry, 2021
Response to lithium varies widely between individuals with bipolar disorder (BD). Polygenic risk scores (PRSs) can uncover pharmacogenomics effects and may help predict drug response.
B. Coombes, V. Millischer, Anthony K. Batzler, Beth Larrabee, L. Hou, S. Papiol, U. Heilbronner, M. Adli, K. Akiyama, N. Akula, A. Amare, R. Ardau, B. Arias, J. Aubry, L. Backlund, M. Bauer, B. Baune, F. Bellivier, A. Benabarre, S. Bengesser, A. Bhattacharjee, P. Cervantes, Hsi-Chung Chen, C. Chillotti, S. Cichon, S. Clark, F. Colom, C. Cruceanu, P. Czerski, N. Dalkner, F. Degenhardt, M. Del Zompo, J. DePaulo, B. Étain, P. Falkai, E. Ferensztajn-Rochowiak, A. Forstner, L. Frisén, S. Gard, J. Garnham, F. Goes, M. Grigoroiu-Serbanescu, P. Grof, Ryota Hashimoto, J. Hauser, S. Herms, P. Hoffmann, S. Jamain, E. Jiménez, J. Kahn, L. Kassem, Tadafumi Kato, J. Kelsoe, S. Kittel-Schneider, B. König, Po-Hsiu Kuo, I. Kusumi, G. Laje, M. Landén, C. Lavebratt, M. Leboyer, S. Leckband, M. Maj, M. Manchia, Lina Martinsson, M. McCarthy, S. McElroy, P. Mitchell, M. Mitjans, Francis M. Mondimore, P. Monteleone, C. Nievergelt, M. Nöthen, Tomáš Dvořáčková Blanka Novák, C. O’Donovan, U. Osby, N. Ozaki, A. Pfennig, C. Pisanu, J. Potash, A. Reif, E. Reininghaus, M. Rietschel, G. Rouleau, J. Rybakowski, M. Schalling, P. Schofield, K. Schubert, Barbara W. Schweizer, G. Severino, T. Shekhtman, P. Shilling, Katzutaka Shimoda, C. Simhandl, C. Slaney, A. Squassina, T. Stamm, P. Stopková, A. Tortorella, G. Turecki, E. Vieta, S. Witt, P. Zandi, J. Fullerton, M. Alda, M. Frye, T. Schulze, F. McMahon, J. Biernacka   +108 more
semanticscholar   +1 more source

Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. [PDF]

, 2019
BackgroundRepetitive Transcranial Magnetic Stimulation (rTMS) is commonly administered to Major Depressive Disorder (MDD) patients taking psychotropic medications, yet the effects on treatment outcomes remain unknown.
Chawla, Shweta A, Cook, Ian A, Hunter, Aimee M, Krantz, David E, Leuchter, Andrew F, Levitt, Jennifer G, Minzenberg, Michael J, Rotstein, Natalie M   +7 more
core   +1 more source

Differential treatment of bipolar disorder with old and new antiepileptic drugs [PDF]

, 1998
Although lithium remains the preferred medication for bipolar disorders, new investigations suggest that only 60 to 80% of patients have a good response with a classical presentation.
Berger, M., Grunze, Heinz, Langosch, J., Normann, C., Walden, Jörg   +4 more
core   +1 more source

Frequency-Specific Changes in the Fractional Amplitude of the Low-Frequency Fluctuations in the Default Mode Network in Medication-Free Patients With Bipolar II Depression: A Longitudinal Functional MRI Study

Frontiers in Psychiatry, 2021
Objective: This study aimed to examine the treatment-related changes of the fractional amplitude of low-frequency fluctuations (fALFF) in the default mode network (DMN) across different bands after the medication-free patients with bipolar II depression ...
Jun Zhou, Xiaoqian Ma, Chunwang Li, Aijun Liao, Zihao Yang, Honghong Ren, Jinsong Tang, Jinguang Li, Zongchang Li, Ying He, Xiaogang Chen   +10 more
semanticscholar   +1 more source

Potentially inappropriate prescribing in nursing home residents detected with the community pharmacist specific GheOP3S-tool [PDF]

, 2016
Background: The Ghent Older People’s Prescriptions community Pharmacy Screening (GheOP3S-)tool was recently developed to screen for potentially inappropriate prescribing (PIP).
Boussery, Koen, Mattelin, Kristof, Mehuys, Els, PATTYN, EVA, Petrovic, Mirko, Somers, Annemie, Tommelein, Eline, Van Damme, Charlotte   +7 more
core   +1 more source

How patients contribute to an online psychoeducation forum for bipolar disorder: a virtual participant observation study [PDF]

, 2015
Background: In a recent exploratory randomized controlled trial, an online psychoeducation intervention for bipolar disorder has been found to be feasible and acceptable to patients and may positively impact on their self-management behaviors and ...
Poole, Ria, Simpson, Sharon, Smith, Daniel   +2 more
core   +3 more sources

Population Pharmacokinetics and Dosing Regimen of Lithium in Chinese Patients With Bipolar Disorder

Frontiers in Pharmacology, 2022
Background: Lithium is an effective medication approved for the treatment of bipolar disorder (BD). It has a narrow therapeutic index (TI) and requires therapeutic drug monitoring.
Zi-bin Jin, Zhuo Wu, Yi-fan Cui, Yi-fan Cui, Xue-peng Liu, Hong-bo Liang, Jia-yong You, Chen-yu Wang   +7 more
doaj   +1 more source

Persistent lithium-induced neurotoxicity: direct effect of lithium and/or hypernatremia? [PDF]

, 2009
Lithium has been used in the treatment of bipolar affective disorder (BAD) for more than 50 years. Features of lithium toxicity include drowsiness, slurred speech, ataxia, psychomotor slowing, polyneuropathy, impaired memory, seizures, coma and death ...
Bourgeois, James A., Popescu, Ioana-Mihaela   +1 more
core   +2 more sources

“Ghost tablet” husks excreted in feces in large bupropion XL overdose [PDF]

, 2018
Background: Extended-release medications are widely prescribed across the spectrum of medical specialties; however, there is heterogeneity in how they are formulated.
Nanagas, Kristine, Overberg, Adam, Purpura, Andrea   +2 more
core   +1 more source